Topic: MS

New data on first-line oral therapies in MS

November 4, 2015  

Late-breaking news at ECTRIMS 2015: ocrelizumab, minocycline and biotin

October 28, 2015  

Long-term outcomes of HSCT in MS

October 10, 2015  

Need for early, effective treatment: MSBase investigators

October 10, 2015  

OPERA I/OPERA II results for ocrelizumab in RRMS

October 10, 2015  

Is MS ever benign?

October 9, 2015  

Novel therapies in development: 4 reports

October 9, 2015  

Predictive value of NEDA and brain atrophy in MS

October 9, 2015  

Too few patients considered candidates for treatment optimization

October 8, 2015  

Current DMTs – an overview of observational studies

October 8, 2015